74 Pro-Angiogenic Effects of the Prolyl-hydroxylase Inhibitor FG-2216/BIQ: Therapeutic Angiogenesis for the Treatment of Chronic Total Occlusions.

74 Pro-Angiogenic Effects of the Prolyl-hydroxylase Inhibitor FG-2216/BIQ: Therapeutic Angiogenesis for the Treatment of Chronic Total Occlusions.

: Percutaneous coronary intervention (PCI) is now the dominant revascularisation therapy for coronary artery disease, with nearly 3 million PCIs undertaken per annum world-wide. One of the last remaining challenges to PCI success is in cases of chronic total occlusions (CTO), where average UK succes...

Full description

Bibliographic Details
Main Authors:	Barnett, G, Schofield, C, Gershlick, A
Format:	Journal article
Language:	English
Published:	2014

Similar Items

The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.
by: Barnett, G, et al.
Published: (2013)

Pro-angiogenic effects of proly-hydroxylase inhibitor FG-2216 and potential for use in a novel strategy of therapeutic angiogenesis for difficult cases of coronary total occlusion
by: Barnett, G, et al.
Published: (2014)

Enhanced Endothelial Tubule Formation in Response to Proly-Hydroxylase Inhibitor FG-2216: A Step Towards Therapeutic Angiogenesis in Chronic Total Occlusions
by: Barnett, G, et al.
Published: (2012)

In-vivo observations on angiogenesis: Dose-dependent effects of the prolyl-4-hydroxylase inhibitor, di-methyl oxalyl-glycine, on arterial development in embryonic zebrafish
by: Kelly, D, et al.
Published: (2008)

In-vivo observations on angiogenesis in embryonic zebrafish: dose-dependent effects of the prolyl-4-hydroxylase inhibitor, Di-methyl oxalyl-glycine, on arterial development
by: Kelly, D, et al.
Published: (2008)

Inhibition of a viral prolyl hydroxylase
by: Langley, G, et al.
Published: (2019)

Prolyl hydroxylases and therapeutics.
by: Smith, T, et al.
Published: (2010)

Exploring the substrate selectivity of oxygen sensing prolyl hydroxylases
by: Lippl, K, et al.
Published: (2015)

Mass spectrometric studies on an oxygen sensing prolyl hydroxylase
by: Mecinovic, J, et al.
Published: (2007)

Regulation of HIF: prolyl hydroxylases.
by: Stolze, I, et al.
Published: (2006)

Substrate selectivity of prolyl hydroxylases
by: McDonough, M
Published: (2018)

Inhibition of HIF prolyl-4-hydroxylases by FG-4497 reduces brain tissue injury and edema formation during ischemic stroke.
by: Stefan Reischl, et al.
Published: (2014-01-01)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
by: Mole, D, et al.
Published: (2003)

2-Oxoglutarate analogue inhibitors of prolyl hydroxylase domain 2.
by: Mecinović, J, et al.
Published: (2009)

Differential prolyl hydroxylation by six Physcomitrella prolyl-4 hydroxylases
by: Christine Rempfer, et al.
Published: (2024-12-01)

Structural basis of prolyl hydroxylase domain inhibition by Molidustat
by: Figg, WD, et al.
Published: (2021)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
by: McNeill, L, et al.
Published: (2002)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
by: Schlemminger, I, et al.
Published: (2003)

Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against renal ischemia/reperfusion injury by inhibiting inflammation
by: A-Feng Miao, et al.
Published: (2021-01-01)

Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
by: Hewitson, K, et al.
Published: (2007)

Structural and mechanistic studies on prolyl hydroxylases
by: Chowdhury, R
Published: (2008)

BIOL 56-ESI-MS studies on prolyl hydroxylase domain 2
by: Mecinovic, J, et al.
Published: (2008)

Chemical inhibition of oxygen-sensing prolyl hydroxylases impairs angiogenic competence of human vascular endothelium through metabolic reprogramming
by: Ratnakar Tiwari, et al.
Published: (2022-10-01)

Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase, and is sensitive to off target inhibition by prolyl hydroxylase domain inhibitors that stabilise Hypoxia Inducible Factor
by: Kiriakidis, S, et al.
Published: (2017)

Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2
by: Richardson, NL, et al.
Published: (2021)

Structural, functional and evolutionary studies on prolyl-hydroxylases
by: Scotti, J
Published: (2014)

Iron homeostasis and its interaction with prolyl hydroxylases.
by: Mole, D
Published: (2010)

Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors
by: Holt-Martyn, J, et al.
Published: (2019)

Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.
by: Flashman, E, et al.
Published: (2010)

Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.
by: Flashman, E, et al.
Published: (2010)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
by: Chan, M, et al.
Published: (2016)

Use of mass spectrometry to probe the nucleophilicity of cysteinyl residues of prolyl hydroxylase domain 2.
by: Mecinović, J, et al.
Published: (2009)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
by: Chowdhury, R, et al.
Published: (2016)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
by: Flashman, E, et al.
Published: (2010)

Effects of orally active hypoxia inducible factor alpha prolyl hydroxylase inhibitor, FG4592 on renal fibrogenic potential in mouse unilateral ureteral obstruction model
by: Kazuya Kabei, et al.
Published: (2020-03-01)

Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases.
by: Chowdhury, R, et al.
Published: (2009)

Mechanism of molecular oxygen diffusion in a hypoxia-sensing prolyl hydroxylase using multiscale simulation
by: Domene, C, et al.
Published: (2020)

Cícero, Do Orador 2.216-290
by: Adriano Scatolin, et al.
Published: (2020-05-01)

Collagen Prolyl Hydroxylases Are Bifunctional Growth Regulators in Melanoma
by: Atkinson, Aithne, et al.
Published: (2020)

Collagen Prolyl 4-Hydroxylase as a Therapeutic Target
by: Vasta, James D., et al.
Published: (2020)